In recent days, a number of stocks in the penny stock space have been buzzing, and it would be a good time for investors to take a closer look into those. Here are four such stocks.
Clean Vision Corporation (OTC:CLNV): The company is involved in running a portfolio of synergistic companies involved in the sustainable green energy and clean technology sectors. On September 26, the Chief Executive Officer of Clean Vision Corporation, Dan Bates, went on ‘The Street Reports Podcast’ and provided an overview of the company.
He started off the podcast by stating that the company would make a significant contribution towards addressing the global plastic pollution problem. Another important thing that Bates spoke about in addition to the company’s overarching goals was the $1.75 million in funding that it had received for its facility in West Virginia.
On September 7, Clean Vision Corporation announced that it had been awarded a forgivable loan worth $1.75 million in line with the Memorandum of Understanding that it had signed with the West Virginia Department of Economic Development on June 1, 2023. As per the terms of the agreement, the company would have to employ at least 40 people in three years for the loan to be forgiven.
In the news release, the company noted that the non-dilutive form of financing would be vital for the company to speed up the eventual launch of its path-breaking plastic waste to a circular fuel plant located in Quincy, Virginia. A subsidiary of Clean Vision, Clean Seas West Virginia Inc., would be responsible for working on a project to address the global problem of plastic pollution. Through its innovative process, plastic feedstock is turned into sustainable fuel. The fuel would be used in the plastic manufacturing industry and promote the circular economy.
Houston Natural Resources Corporation (OTC:HNRC), now known as Cunningham Natural Resources Corp., and the Chief Executive Officer of the company, Frank Kristan, went on the ‘The Street Reports Podcast’ on September 26 and discussed certain recent developments. He started off by noting that following the acquisition of Cunningham Energy Ltd. earlier this year, the company’s name would be changed from Houston Natural Resources Corporation to Cunningham Natural Resources Corporation.
He noted that the name change was under review by FINRA. Another point of discussion was the acquisition of a 10% stake by the company in Kharrouba Copper Company Inc. in August. He noted that the company was currently looking, in addition to traditional gas and energy, for energy transition materials. Hence, the company was looking into mining opportunities in the copper and lithium spaces, Kristan noted.
On September 21, the company was in the news after it announced that it had completed the sales of its subsidiary assets successfully with an enterprise value of $18 million. The transaction realized $0.15 per share. In the news release, Houston Natural Resources Corporation noted that the transaction had helped it make strong progress toward its objectives.
In the news release, the company revealed that it had signed an agreement to exchange its preferred stock with a market valuation of $18 million for the assets of Houston Natural Resources Ltd. The company would be focused mainly on the oil and gas sectors, other than energy transition materials and rare earth metals.
Northwest Biotherapeutics (OTC:NWBO): The biotech company is focused on the development of customized immunotherapy products that are meant to treat different forms of cancer more effectively than existing treatments. The products from Northwest Biotherapeutics are without the usual toxicities related to treatments like chemotherapy and are competitively priced for consumption in the European and North American markets.
On September 12, the company announced that it had added Dr. Linda Liau, MD, PHD, MBA, to its Scientific Advisory Board. An inductee of the National Academy of Medicine, Dr. Liau is a highly accomplished medical expert and has also been the lead investigator in the Phase 3 trial of the company’s product, DCVax-L.
On August 29, the company announced that it had made plans to send in a Marketing Authorisation Application (MAA) to the United Kingdom’s regulatory agency, the Medicines and Healthcare Products Regulatory Agency (MHRA). In its news release, Northwest announced that the application had been for the commercial approval of the treatment of glioblastoma with DCVax-L.
Astra Energy Inc. (OTC:ASRE) is an integrated solutions company involved in the development and investments in clean and renewable energy projects. Astra Energy Inc. is mainly associated with projects in those markets where supply is limited, demand is high, and a resultant gap in the market could be filled.
On September 25, the company announced that it had reached an agreement with Holcomb Energy Systems LLC (HES) for the exclusive global manufacturing rights for the HES In-Line Power Generator (“ILPG”) and the HES Self-Sustaining Power Plant. In the news release, the company noted that both were exceptional technologies that were in a position to revolutionize the energy space.
As per the provisions of the agreement, Astra Energy would manufacture both products in-house. Additionally, the company would sublicense the manufacturing of the products to joint venture partners. More importantly, both HES technologies are not only scalable but also offer a large number of applications in the worldwide clean energy space.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.